References
- KleinmanSBuschMPKorelitzJJSchreiberGBThe incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infectionTransfus Med Rev19971131551729243769
- UNAIDSGlobal Report on AIDS Epidemic: Treatment and care2008 Available from: www.unaids.org/sites/default/files/media_asset/jc1510_2008globalreport_en_0.pdfAccessed 09/04/2018
- JayaramanSChalabiZPerelPGuerrieroCRobertsIThe risk of transfusion-transmitted infections in sub-Saharan AfricaTransfusion201050243344219843290
- FasolaFOtegbayoIPost-transfusion viral hepatitis in sickle cell anaemia: retrospective-prospective analysisNiger J Clin Pract2002511619
- YoodaAPSoubeigaSTNebieKYImpact of multiplex PCR in reducing the risk of residual transfusion-transmitted human immunodeficiency and hepatitis B and C viruses in Burkina FasoMediterr J Hematol Infect Dis2018101e201804130002797
- NagaloMBSanouMBisseyeCSeroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009Blood Transfus20119441942421839011
- DiarraBYonliATOuattaraAKWorld hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goalVirol J201815112130081915
- NébiéKYOlingerCMKafandoELack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion securityTransfus Clin Biol2007145446452 French18295528
- World Health Organisation2010Geneva, Screening Donated Blood for Transfusion Available from: http://www.who.int/bloodsafety/ScreeningDonatedBloodforTransfusion.pdfAccessed 9 February 2016
- WHOBlood Safety and Blood Supply. Checklist. N° 279Geneva, SwitzerlandWHO2013
- SchreiberGThe risk of transfusion-transmitted viral infections. The Epidemiology Donor StudyN Engl J Med199633426173417358637520
- JacksonBRBuschMPStramerSLAuBuchonJPThe cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donationsTransfusion200343672172912757522
- CouroucéAMPillonelJEstimation du risque de transmission des virus des hépatites B et C et des rétrovirus humains par transfusion de dérivés sanguins labiles. [Risk of transfusion-transmitted viral infections]Transfus Clin Biol19963113188640309
- KaniaDSangaréLSakandéJA new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina FasoTransfusion200949102237224019903285
- CollenbergEOuedraogoTGanaméJSeroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysisJ Med Virol200678568369216555290
- NagaloBMBisseyeCSanouMSeroprevalence and incidence of transfusion-transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West AfricaTrop Med Int Health201217224725321988100
- CNLS/ISTRapport d’activité sur la riposte au SIDA au Burkina Faso2016 Available from: http://www.unaids.org/en/file/110917/download?token=6aVHZQzYAccessed 09/04/2018
- TaoICompaoréTRDiarraBSeroepidemiology of hepatitis B and C viruses in the general population of Burkina FasoHepat Res Treat2014201478184325161770
- MedaNTuaillonEKaniaDHepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional studyBull World Health Organ2018961175075930455530
- ZebaMTSanouMBisseyeCCharacterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina FasoBlood Transfus201412Suppl 1s5424599906
- KafandoENébiéYSSKienouKDahourouHSimporeJRisk behavior among ineligible blood donors in a blood transfusion center (Burkina Faso)J Hematol Blood Transfus Disord20174015
- KouraMHemaACoulibalyAIncidence et risque résiduel de transmission des virus de l’hépatite B et C par transfusion sanguine Bobo-Dioulasso (Burkina Faso): Étude de cohorte. [Incidence and residual risk of transmission of hepatitis B and C by blood transfusion in Bobo-Dioulasso (Burkina Faso): cohort study]Science et technique, Sciences de la santé20174022533
- StramerSLDoddRYBrodskyJPThe value of screening signal-to-cutoff ratios for hepatitis C virus antibody confirmationTransfusion20135371497150023176156
- PillonelJLegrandDSommenCLapercheSSurveillance épidémiologique des donneurs de sang et risque résiduel de transmission du VIH, de l’HTLV, du VHC et du VHB par transfusion en France entre 2008 et 2010 [Epidemiological surveillance of blood donors and residual risk of transfusion transmission of HIV, HTLV, HCV and HBV in France, 2008 to 2010]Bull Epidemiol Hebd201239–40438442
- ZouSStramerSLDoddRYDonor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donationsTransfus Med Rev201226211912821871776
- OuattaraHSiransy-BoguiLFretzCResidual risk of HIV, HVB and HCV transmission by blood transfusion between 2002 and 2004 at the Abidjan National Blood Transfusion CenterTransfus Clin Biol200613424224516822686
- Touré-FallAODièyeTNSallAResidual risk of transmission of HIV and HBV, in Senegalese national blood bank from 2003 to 2005Transfus Clin Biol2009165–6439443 French19926508
- RerambiahLKRerambiahLEBengoneCDjoba SiawayaJFSiawayaJFDThe risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion CentreBlood Transfus201412333024333085